| Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S , Boumpas DT , Brodin N, Bruce IN, González-Gay MÁ, Jacobsen S, Kerekes G, Marchiori F, Mukhtyar C, Ramos-Casals M, Sattar N, Schreiber K, Sciascia S, Svenungsson E, Szekanecz Z, Tausche AK, Tyndall A, van Halm V, Voskuyl A, Macfarlane GJ, Ward MM, Nurmohamed MT, Tektonidou MG . EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022 Jun;81(6):768-779. |
| Fanouriakis A , Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT . 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019 Jun;78(6):736-745. |
| Fragoulis GE, Koutsianas C, Fragiadaki K, Mariolis I, Panopoulos S, Tsalapaki C, Pappa M, Dimitroulas T, Tektonidou MG, Vassilopoulos D, Sfikakis PP . Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series. Ann Rheum Dis. 2022 Jun |
| Papagoras C, Fragoulis GE , Zioga N, Simopoulou T, Deftereou K, Kalavri E, Zampeli E, Gerolymatou N, Kataxaki E, Melissaropoulos K, Panopoulos S, Fragiadaki K, Evangelatos G, Bournia VK, Arida A, Karamanakos A, Pappa M, Panagiotopoulos A, Koutsianas C, Mparouta G, Dimitroulas T, Liossis SN, Tektonidou MG , Kravvariti E, Kougkas N, Georgiou P, Voulgari P, Elezoglou A, Bogdanos DP, Vassilopoulos D, Sfikakis PP . Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases. Ann Rheum Dis. 2021 Nov 10:annrheumdis-2021-221539. |
| Bournia VK, Fragoulis GE, Mitrou P, Mathioudakis K, Tsolakidis A, Konstantonis G, Vourli G, Paraskevis D, Tektonidou MG, Sfikakis PP. All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019. RMD Open. 2021 Nov;7(3):e001694. |
| Evangelatos G, Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP, Tektonidou MG . Atherosclerosis progression in antiphospholipid syndrome is comparable to diabetes mellitus: a 3-year prospective study. Rheumatology (Oxford). 2021 Nov 30:keab882 |
| Keramiotou K, Anagnostou C, Konstantonis G, Fragiadaki K, Kataxaki E, Sfikakis PP, Tektonidou MG . SLICC-Frailty Index is independently associated with impaired physical function, activities of daily living, and quality of life measures. Rheumatology (Oxford). 2022 Jan 7:keac001 |
| Fragoulis GE , Karamanakos A, Arida A, Bournia VK, Evangelatos G, Fanouriakis A , Fragiadaki K, Kravvariti E, Laskari K, Panopoulos S, Papazoglou N, Pappa M, Tektonidou MG, Sfikakis PP . Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases. RMD Open. 2022 Mar;8(1):e002279. |
| Panopoulos S, Thomas K , Georgiopoulos G, Boumpas D, Katsiari C, Bertsias G, Drosos AA, Boki K, Dimitroulas T, Garyfallos A, Papagoras C, Katsimbri P, Tziortziotis A, Adamichou C, Kaltsonoudis E, Argyriou E, Vosvotekas G, Sfikakis PP, Vassilopoulos D, Tektonidou MG. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Rheumatology (Oxford). 2021 Jan 5;60(1):170-178. |
| Thomas K , Lazarini A, Kaltsonoudis E, Drosos A, Papalopoulos I, Sidiropoulos P, Tsatsani P, Gazi S, Pantazi L, Boki KA, Katsimbri P, Boumpas D, Fragkiadaki K, Tektonidou M, Sfikakis PP , Karagianni K, Sakkas LI, Grika EP, Vlachoyiannopoulos PG , Evangelatos G, Iliopoulos A, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Areti M, Georganas C, Vounotrypidis P, Kitas GD, Vassilopoulos D . Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients. Ther Adv Musculoskelet Dis. 2020 Sep 28;12:1759720X20937132. |
| Evangelatos G, Fragoulis GE , Klavdianou K, Moschopoulou M, Vassilopoulos D , Iliopoulos A. Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience. Rheumatology (Oxford). 2021 May 14;60(5):2375-2382 |
| Patrolling human SLE haematopoietic progenitors demonstrate enhanced extramedullary colonisation; implications for peripheral tissue injury. Kokkinopoulos I, Banos A, Grigoriou M, Filia A, Manolakou T, Alissafi T, Malissovas N, Mitroulis I, Verginis P, Boumpas DT . Sci Rep. 2021 Aug 3;11(1):15759. |
| Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients. Thomas K , Argyriou E, Kapsala N, Panagiotopoulos A, Chalkia A, Hadziyannis E, Boki K, Katsimbri P, Boumpas DT , Giannou P, Petras D, Vassilopoulos D . Arthritis Res Ther. 2021 Mar 20;23(1):90. |
| Nikolopoulos D, Kitsos D, Papathanasiou M, Chondrogianni M, Theodorou A, Garantziotis P, Pieta A, Doskas T, Bertsias G, Voumvourakis K, Boumpas DT, Fanouriakis A . Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Rheumatology (Oxford). 2021 Sep 1;60(9):4166-4174 |
| Fanouriakis A , Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT . 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020 Jun;79(6):713-723 |
| Thomas K , Lazarini A, Kaltsonoudis E, Voulgari PV, Drosos AA, Repa A, Sali AMI, Sidiropoulos P, Tsatsani P, Gazi S, Evangelia A, Boki KA, Katsimbri P, Boumpas D, Fragkiadaki K, Tektonidou MG, Sfikakis PP , Karagianni K, Sakkas LI, Grika EP, Vlachoyiannopoulos PG, Evangelatos G, Iliopoulos A, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Areti M, Georganas C, Vounotrypidis P, Georgiopoulos G, Kitas GD, Vassilopoulos D. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis. Rheumatology (Oxford). 2021 May 14;60(5):2223-2230 |
| Vlachoyiannopoulos PG , Magira E, Alexopoulos H, Jahaj E, Theophilopoulou K, Kotanidou A, Tzioufas AG . Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020 Dec;79(12):1661-1663 |
| Palamidas DA, Argyropoulou OD , Georgantzoglou N, Karatza E, Xingi E, Kapsogeorgou EK , Anagnostopoulos CD, Lazaris AC, Ritis K, Goules AV , Kambas K, Tzioufas AG. Neutrophil extracellular traps in giant cell arteritis biopsies: presentation, localization and co-expression with inflammatory cytokines. Rheumatology (Oxford). 2022 Apr 11;61(4):1639-1644 |
| Chatzis LG , Stergiou IE, Goules AV , Pezoulas V, Tsourouflis G, Fotiadis D, Tzioufas AG, Voulgarelis M . Rheumatology (Oxford). Clinical picture, outcome, and predictive factors of lymphoma in primary Sjogren’s syndrome. Results from a harmonized dataset (1981-2021). 2021 Dec 23:keab939 |
| Fragoulis GE , Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S , Konstantonis G, Iliopoulos A, Chatzidionysiou K, Sfikakis PP , Tektonidou MG . Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis. 2020 Dec 8;12:1759720X20976975. doi: 10.1177/1759720X20976975. |
| Thomas K, Lazarini A, Kaltsonoudis E, Voulgari PV, Drosos AA, Repa A, Sali AMI, Sidiropoulos P, Tsatsani P, Gazi S, Evangelia A, Boki KA, Katsimbri P, Boumpas D, Fragkiadaki K, Tektonidou MG, Sfikakis PP , Karagianni K, Sakkas LI, Grika EP, Vlachoyiannopoulos PG , Evangelatos G, Iliopoulos A, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Areti M, Georganas C, Vounotrypidis P, Georgiopoulos G, Kitas GD, Vassilopoulos D. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis. Rheumatology (Oxford). 2020 Dec 9:keaa557. doi: 10.1093/rheumatology/keaa557 |
| Patsouras M, Tsiki E, Karagianni P, Vlachoyiannopoulos PG. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome. J Autoimmun. 2020 Dec;115:102527. doi: 10.1016/j.jaut.2020. |
| Vlachogiannis NI, Pappa M, Ntouros PA, Nezos A, Mavragani CP , Souliotis VL, Sfikakis PP. Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis. Front Immunol. 2020 Oct 2;11:582401. doi: 10.3389/fimmu.2020.582401. |
| Goules AV, Argyropoulou OD, Pezoulas VC, Chatzis L, Critselis E, Gandolfo S, Ferro F, Binutti M, Donati V, Zandonella Callegher S, Venetsanopoulou A, Zampeli E, Mavrommati M, Voulgari PV, Exarchos T, Mavragani CP, Baldini C, Skopouli FN, Fotiadis DI, De Vita S, Moutsopoulos HM, Tzioufas AG . Primary Sjögren’s Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development. Front Immunol. 2020 Oct 19;11:594096. doi: 10.3389/fimmu.2020.594096. |
| Tektonidou MG, Kravvariti E, Vlachogiannis NI, Georgiopoulos G, Mantzou A, Sfikakis PP , Stellos K, Stamatelopoulos K. Clinical value of amyloid-beta1-40 as a marker of thrombo-inflammation in anti-phospholipid syndrome. Rheumatology (Oxford). 2020 Oct 7:keaa548. doi: 10.1093/rheumatology/keaa548. |
| Alissafi T, Kalafati L, Lazari M, Filia A, Kloukina I, Manifava M, Lim JH, Alexaki VI, Ktistakis NT, Doskas T, Garinis GA, Chavakis T, Boumpas DT, Verginis P . Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity. Cell Metab. 2020 Oct 6;32(4):591-604.e7. doi: 10.1016/j.cmet.2020.07.001. contributed equally |
| D Argyropoulou, V Pezoulas, L Chatzis , E Critselis, S Gandolfo, F Ferro, L Quartuccio V Donati, E Treppo, C R Bassoli, A Venetsanopoulou , E Zampeli, M Mavrommati, P V Voulgari, T E Exarchos, C P Mavragani , C Baldini, F N Skopouli, M Galli, D Ι Fotiadis, S De Vita, H M Moutsopoulos, A G Tzioufas*, A V Goules* . Cryoglobulinemic vasculitis in primary Sjögren’s Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. Semin Arthritis Rheum. 2020 Oct;50(5):846-853. doi: 10.1016/j.semarthrit.2020.07.013. (*equal contribution/corresponding author: Tzioufas A) |
| Thomas K , Lazarini A, Kaltsonoudis E, Drosos A, Papalopoulos I, Sidiropoulos P, Tsatsani P, Gazi S, Pantazi L, Boki KA, Katsimbri P, Boumpas D, Fragkiadaki K, Tektonidou M, Sfikakis PP, Karagianni K, Sakkas LI, Grika EP, Vlachoyiannopoulos PG, Evangelatos G, Iliopoulos A, Dimitroulas T, Garyfallos A, Melissaropoulos K, Georgiou P, Areti M, Georganas C, Vounotrypidis P, Kitas GD, Vassilopoulos D. Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients. Ther Adv Musculoskelet Dis. 2020 Sep 28;12:1759720X20937132. |
| Mavragani CP, Nezos A, Dovrolis N, Andreou NP, Legaki E, Sechi LA, Bamias G, Gazouli M. Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota. Inflamm Bowel Dis. 2020 Sep 18;26(10):1543-1553. |
| Tektonidou MG , Katsifis G, Georgountzos A, Theodoridou A, Koukli EM, Kandili A, Giokic-Kakavouli G, Karatsourakis TD. Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Ther Adv Musculoskelet Dis. 2020 Sep 28;12:1759720X20949088. doi: 10.1177/1759720X20949088. |
| Panopoulos S, Thomas K , Georgiopoulos G, Boumpas D, Katsiari C, Bertsias G, Drosos AA, Boki K, Dimitroulas T, Garyfallos A, Papagoras C, Katsimbri P, Tziortziotis A, Adamichou C, Kaltsonoudis E, Argyriou E, Vosvotekas G, Sfikakis PP, Vassilopoulos D, Tektonidou MG . Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Rheumatology (Oxford). 2021 Jan 5;60(1):170-178. doi: 10.1093/rheumatology/keaa321. |
| Nezos A, Argyropoulou OD , Klinaki E, Marketos N, Karagianni P, Eliopoulos E, Vlachoyiannopoulos P , Maritsi DN, Tzioufas AG . Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center. Rheumatology (Oxford). 2020 Jun 1;59(6):1241-1246. doi: 10.1093/rheumatology/kez424. |
| Laskari K, Pentazos G, Pitsilka D, Raftakis J, Konstantonis G, Toutouzas K, Siores E, Tektonidou M, Sfikakis PP. Joint microwave radiometry for inflammatory arthritis assessment. Rheumatology (Oxford). 2020 Apr 1;59(4):839-844. doi: 10.1093/rheumatology/kez373. |
| Kravvariti E , Koutsogianni A, Samoli E, Sfikakis PP , Tektonidou MG . The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study. Autoimmun Rev. 2020 Apr;19(4):102491. doi: 10.1016/j.autrev.2020.102491. 7.767 |
| Vakrakou AG, Svolaki IP, Evangelou K, Gorgoulis VG, Manoussakis MN . Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjögren’s syndrome. J Autoimmun. 2020 Mar;108:102381. doi: 10.1016/j.jaut.2019.102381. |
| Drosos GC, Konstantonis G, Sfikakis PP , Tektonidou MG . Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus. Eur J Prev Cardiol. 2020 Mar 2:2047487320906650. doi: 10.1177/2047487320906650. |
| Panopoulos S , Chatzidionysiou Κ, Tektonidou MG, Bournia VK, Drosos AA, Liossis SC, Dimitroulas T, Sakkas L, Boumpas D, Voulgari PV, Daoussis D, Thomas K, Georgiopoulos G, Vosvotekas G, Garyfallos Α, Sidiropoulos P, Bertsias G, Vassilopoulos D, Sfikakis PP . Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort. Arthritis Res Ther. 2020 Mar 23;22(1):56. doi: 10.1186/s13075-020-2140-3. |
| Grigoriou M, Banos A, Filia A, Pavlidis P, Giannouli S, Karali V, Nikolopoulos D, Pieta A, Bertsias G, Verginis P, Mitroulis I, Boumpas DT . Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus. Ann Rheum Dis. 2020 Feb;79(2):242-253. doi: 10.1136/annrheumdis-2019-215782. 16.102 |
| Tektonidou MG, Dasgupta A, Ward MM. Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA. Rheumatology (Oxford). 2019 Oct 1;58(10):1794-1801. doi: 10.1093/rheumatology/kez103. |
| Panousis NI, Bertsias GK, Ongen H, Gergianaki I , Tektonidou MG , Trachana M, Romano-Palumbo L, Bielser D, Howald C, Pamfil C, Fanouriakis A, Kosmara D, Repa A, Sidiropoulos P, Dermitzakis ET, Boumpas DT . Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Ann Rheum Dis. 2019 Aug;78(8):1079-1089. doi: 10.1136/annrheumdis-2018-214379. |
| Palli E, Kravvariti E , Tektonidou MG . Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations. Front Immunol. 2019 Mar 15;10:487. doi: 10.3389/fimmu.2019.00487. |
| Unlu O, Erkan D, Barbhaiya M, Andrade D, Nascimento I, Rosa R, Banzato A, Pengo V, Ugarte A, Gerosa M, Ji L, Efthymiou M, Branch DW, de Jesus GR, Tincani A, Belmont HM, Fortin PR, Petri M, Rodriguez E, Pons-Estel GJ, Knight JS, Atsumi T, Willis R, Zuily S, Tektonidou MG ; AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Investigators. The Impact of Systemic Lupus rythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis Care Res (Hoboken). 2019 Jan;71(1):134-141. doi: 10.1002/acr.23584. |
| Patsouras MD, Karagianni P, Kogionou P, Vlachoyiannopoulos PG. Differential CpG methylation of the promoter of interleukin 8 and the first intron of tissue factor in Antiphospholipid syndrome. J Autoimmun. 2019 Aug;102:159-166. doi: 10.1016/j.jaut.2019.05.001. |
| Apostolou E, Moustardas P, Iwawaki T, Tzioufas AG*, Spyrou G* . Ablation of the Chaperone Protein ERdj5 Results in a Sjögren’s Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients. Front Immunol. 2019 Mar 22;10:506. doi: 10.3389/fimmu.2019.00506. eCollection 2019 (equal senior and corresponding authors) |
| Frangou E, Chrysanthopoulou A, Mitsios A, Kambas K, Arelaki S, Angelidou I, Arampatzioglou A, Gakiopoulou H, Bertsias GK, Verginis P , Ritis K, Boumpas DT . REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A). Ann Rheum Dis. 2019 Feb;78(2):238-248. doi: 10.1136/annrheumdis-2018-213181. |
| Panopoulos S, Tektonidou M, Drosos AA, Liossis SN, Dimitroulas T, Garyfallos A, Sakkas L, Boumpas D , Voulgari PV, Daoussis D, Thomas K , Georgiopoulos G, Vosvotekas G, Vassilopoulos D, Sfikakis PP . Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study. Arthritis Res Ther. 2018 Dec 4;20(1):267. doi: 10.1186/s13075-018-1771-0. |
| Kravvariti E , Konstantonis G, Sfikakis PP, Tektonidou MG . Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity. Rheumatology (Oxford). 2018 Dec 1;57(12):2158-2166. doi: 10.1093/rheumatology/key233. |
| Fanouriakis A, Adamichou C, Koutsoviti S, Panopoulos S , Staveri C, Klagou A, Tsalapaki C, Pantazi L, Konsta S, Mavragani CP , Dimopoulou D, Ntali S, Katsikas G, Boki KA, Vassilopoulos D, Konstantopoulou P, Liossis SN, Elezoglou A, Tektonidou M, Sidiropoulos P, Erden A, Sfikakis PP, Bertsias G, Boumpas DT . Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. Semin Arthritis Rheum. 2018 Dec;48(3):467-474 |
| Kampolis CF, Venetsanopoulou AI, Karakontaki F, Polychronopoulos V, Vlachoyiannopoulos P, Tzioufas AG . How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study. Autoimmun Rev. 2018 Nov;17(11):1124-1133. doi: 10.1016/j.autrev.2018.06.004 |
| Kapsogeorgou EK , Papageorgiou A, Protogerou AD, Voulgarelis M , Tzioufas AG . Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren’s syndrome. Ann Rheum Dis. 2018 Aug;77(8):1200-1207. doi: 10.1136/annrheumdis-2017-212639 |
| Gkirtzimanaki K, Kabrani E, Nikoleri D, Polyzos A, Blanas A, Sidiropoulos P, Makrigiannakis A, Bertsias G, Boumpas DT*, Verginis P* . IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion. Cell Rep. 2018 Oct 23;25(4):921-933.e5. doi: 10.1016/j.celrep.2018.09.001. *contributed equally |
| Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M, Moutsopoulos HM , Mavragani CP. B-cell activating factor and related genetic variants in lupus related atherosclerosis. J Autoimmun. 2018 Aug;92:87-92. doi: 10.1016/j.jaut.2018.05.002 |
| Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP , Tektonidou MG . Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort. Autoimmun Rev. 2018 Aug;17(8):816-820. doi: 10.1016/j.autrev.2018.02.008 |
| Vakrakou AG, Boiu S, Ziakas PD, Xingi E, Boleti H, Manoussakis MN . Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren’s syndrome fueled by inflammagenic DNA accumulations. J Autoimmun. 2018 Jul;91:23-33. doi: 10.1016/j.jaut.2018.02.010 |
| Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP , Tektonidou MG . Carotid and femoral atherosclerosis in antiphospholipid syndrome: Equivalent risk with diabetes mellitus in a case-control study. Semin Arthritis Rheum. 2018 Jun;47(6):883-889. doi: 10.1016/j.semarthrit.2017.10.015. |
| Mavragani CP, Nezos A, Sagalovskiy I, Seshan S, Kirou KA, Crow MK. Defective regulation of L1 endogenous retroelements in primary Sjogren’s syndrome and systemic lupus erythematosus: Role of methylating enzymes. J Autoimmun. 2018 Mar;88:75-82. doi: 10.1016/j.jaut.2017.10.004 |
| Papadaki E, Fanouriakis A, Kavroulakis E, Karageorgou D, Sidiropoulos P, Bertsias G, Simos P, Boumpas DT . Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus. Ann Rheum Dis. 2018 Mar;77(3):441-448. doi: 10.1136/annrheumdis-2017-212285. |
| Vakrakou AG, Polyzos A, Kapsogeorgou EK, Thanos D, Manoussakis MN . Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren’s syndrome patients imposed by intrinsic NF-κB activation. J Autoimmun. 2018 Jan;86:62-74. doi: 10.1016/j.jaut.2017.09.007. |
| Makris A, Adamidi S, Koutsianas C, Tsalapaki C , Hadziyannis E, Vassilopoulos D . Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients. Front Immunol. 2018 Jan 10;8:1967. doi: 10.3389/fimmu.2017.01967. |
| Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K , Pentazos G, Laskari K, Tektonidou M , Markomichelakis N. Drug-Free Long-Term Remission in Severe Behçet’s Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment. Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002/art.40235. |
| Tektonidou MG , Lewandowski LB, Hu J, Dasgupta A, Ward MM. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017 Dec;76(12):2009-2016. doi: 10.1136/annrheumdis-2017-211663. |
| Gergianaki I, Fanouriakis A, Repa A, Tzanakakis M, Adamichou C, Pompieri A, Spirou G, Bertsias A, Kabouraki E, Tzanakis I, Chatzi L, Sidiropoulos P, Boumpas DT*, Bertsias GK*. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece. Ann Rheum Dis. 2017 Dec;76(12):1992-2000. doi: 10.1136/annrheumdis-2017-211206. *contributed equally |
| Arida A, Protogerou AD, Konstantonis G, Fragiadaki K , Kitas GD , Sfikakis PP. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities. Rheumatology (Oxford). 2017 Jun 1;56(6):934-939. doi: 10.1093/rheumatology/kew506. |
| Tektonidou MG , Kravvariti E, Konstantonis G, Tentolouris N, Sfikakis PP , Protogerou A. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis. Autoimmun Rev. 2017 Mar;16(3):308-312. doi: 10.1016/j.autrev.2017.01.009. |
| Mavragani CP , Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. Arthritis Rheumatol. 2016 Nov;68(11):2686-2696. |
| Sophia Lionaki 1, Clio P Mavragani 2, Alexandre Karras 3, George Liapis 4, George Somarakis 5, John N Boletis 6, Alexandros Drosos 5, Athanasios G Tzioufas 7, Loic Guillevin 3, Haralampos M Moutsopoulos 7. Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis. J Autoimmun. 2016 Aug;72:57-64. doi: 10.1016/j.jaut.2016.05.004. (1, 2 Equally contributed ) |
| Tektonidou MG, Wang Z, Ward MM. Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012. Arthritis Rheumatol. 2016 Nov;68(11):2680-2685 |
| Karamanolis GP, Panopoulos S , Denaxas K, Karlaftis A, Zorbala A, Kamberoglou D, Ladas SD, Sfikakis PP. The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial. Arthritis Res Ther. 2016 Sep 1;18(1):195. doi: 10.1186/s13075-016-1094-y. |
| Souliotis VL , Vougas K, Gorgoulis VG, Sfikakis PP. Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus. Arthritis Res Ther. 2016 Aug 4;18(1):182. doi: 10.1186/s13075-016-1081-3. |
| Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome. Fragoulis GE , Fragkioudaki S, Reilly JH, Kerr SC, McInnes IB, Moutsopoulos HM. J Autoimmun. 2016 Sep;73:85-91. doi: 10.1016/j.jaut.2016.06.008. Epub 2016 Jun 22. IF6.65 |
| Tektonidou MG , Dasgupta A, Ward MM. Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis. Arthritis Rheumatol. 2016 Jun;68(6):1432-41. doi: 10.1002/art.39594. |
| Protogerou AD, Aissopou EK, Argyris A, Nasothimiou EG, Konstantonis GD , Karamanou M, Papaioannou TG, Blacher J, Safar ME , Sfikakis PP . Phenotypes of office systolic blood pressure according to both brachial and aortic measurements: frequencies and associations with carotid hypertrophy in 1861 adults. J Hypertens. 2016 Jul;34(7):1325-30. doi: 10.1097/HJH.0000000000000955. |
| Vlachou K, Mintzas K, Glymenaki M, Ioannou M, Papadaki G, Bertsias GK, Sidiropoulos P, Boumpas DT, Verginis P . Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation. Arthritis Rheumatol. 2016 Feb;68(2):449-61. doi: 10.1002/art.39441. contributed equally |
| Karageorgas T, Fragioudaki S, Nezos A, Karaiskos D, Moutsopoulos HM, Mavragani CP . Fatigue in Primary Sjögren’s Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations. Arthritis Care Res (Hoboken). 2016 Jan;68(1):123-31. doi: 10.1002/acr.22720. |
